Artwork

Content provided by Dr Neil Love. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr Neil Love or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

IDH-Mutant Low-Grade Glioma — An Interview with Dr Patrick Y Wen on Current and Future Management Strategies

54:07
 
Share
 

Manage episode 490630601 series 1464352
Content provided by Dr Neil Love. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr Neil Love or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

Featuring an interview with Dr Patrick Y Wen, including the following topics:

  • Glioma classification (0:00)
  • Efficacy and safety of vorasidenib in the management of IDH-mutant gliomas (4:50)
  • Case: A woman in her early 30s with a Grade 2 astrocytoma and an IDH R132H mutation and residual disease postoperatively (11:55)
  • Case: A man in his early 40s experiencing stable disease with vorasidenib after subtotal resection (21:46)
  • Ongoing trial investigating vorasidenib in IDH-mutant gliomas (27:30)
  • Current and emergent strategies for the management of glioblastoma (31:27)
  • Optimizing patient care and quality of life (46:24)

CME information and select publications

  continue reading

795 episodes

Artwork
iconShare
 
Manage episode 490630601 series 1464352
Content provided by Dr Neil Love. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr Neil Love or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

Featuring an interview with Dr Patrick Y Wen, including the following topics:

  • Glioma classification (0:00)
  • Efficacy and safety of vorasidenib in the management of IDH-mutant gliomas (4:50)
  • Case: A woman in her early 30s with a Grade 2 astrocytoma and an IDH R132H mutation and residual disease postoperatively (11:55)
  • Case: A man in his early 40s experiencing stable disease with vorasidenib after subtotal resection (21:46)
  • Ongoing trial investigating vorasidenib in IDH-mutant gliomas (27:30)
  • Current and emergent strategies for the management of glioblastoma (31:27)
  • Optimizing patient care and quality of life (46:24)

CME information and select publications

  continue reading

795 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play